Evidence for more than one Parkinson's disease-associated variant within the HLA region.
about
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesA genetic basis for the variable effect of smoking/nicotine on Parkinson's disease.Mapping Bias Overestimates Reference Allele Frequencies at the HLA Genes in the 1000 Genomes Project Phase I Data.Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?The MHC locus and genetic susceptibility to autoimmune and infectious diseases.Major histocompatibility complex genomics and human disease.Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Aspects of innate immunity and Parkinson's disease.The genetics of Parkinson's disease: progress and therapeutic implicationsCommon Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study.Association of Parkinson disease with structural and regulatory variants in the HLA regionThe role of innate and adaptive immunity in Parkinson's disease.Inflammation in Parkinson's disease: role of glucocorticoids.Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.HLA-DRA is associated with Parkinson's disease in Iranian population.HLA-DRA rs3129882 A/G polymorphism was not a risk factor for Parkinson's disease in Chinese-based populations: a meta-analysis.
P2860
Q26767289-8EA04A3B-8CF9-44F4-9B2D-BE3EF5F2F6E6Q30531483-D0649C94-D091-4688-BEE8-AADEE56111E4Q30912274-04165707-CF78-4E42-9588-8D4D469A3B78Q33353554-C2E6F55C-0DB5-4A53-85FB-1C5D1D37F3BCQ33608703-136CFE68-1D2D-434B-A0AB-4838794C760FQ34359146-0D63A812-A0F6-477A-889C-0250D7D65A9CQ34481921-8CB62C34-C40B-40E7-B718-638B6AB618BBQ35510197-6B32D517-7F92-4A3D-A8A5-4C9988C01669Q35813131-C622ACEC-7E0B-47DE-A64F-C8DA38F14194Q36626825-253B42F2-66B9-4F0B-ABEA-AA19A896AE1DQ36858244-3001B674-5BC3-4C5A-9199-8068448DFFAAQ37298135-9B3A9149-A627-4A57-BA40-BF54E3DECA0FQ38166155-9EF5DE8A-5341-4400-A771-C366D10CFE96Q38425458-0A910AEE-B9AF-4429-83E5-C153BE4CF7BFQ39151939-F58DE85C-0318-47CC-8A50-846CA7F14159Q39392775-D669FD84-1DDD-4479-8DF5-2C4C8F8992AFQ43823053-46AEE9D6-079F-4AD3-B81F-F2A6F9688C37Q45904071-B285FCF1-34C2-4D07-8FD0-A70BFB13046D
P2860
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@ast
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@en
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@nl
type
label
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@ast
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@en
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@nl
prefLabel
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@ast
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@en
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@nl
P2093
P2860
P1433
P1476
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
@en
P2093
Erin M Hill-Burns
Glenys Thomson
Haydeh Payami
P2860
P304
P356
10.1371/JOURNAL.PONE.0027109
P407
P577
2011-11-09T00:00:00Z